Pharmaceuticals News

Applied Biologics announces XWRAP® translational research accepted for presentation at SAWC Fall 2026 in Las Vegas.

Craif closes $33M Series D to launch its non-invasive, urine-based pancreatic cancer test in the U.S. under new Chief Medical Officer Nick Bevins.

Society for Science today announced the selection of 100 educators for it 2026–2027 Advocate Program.

Syneos Health advances its AI-powered clinical ecosystem to accelerate insights, optimize trial performance and enable faster, more informed decisions.

Oncolytics submitted a Type D meeting request for REO 033, receiving feedback from the FDA and aligning on potential expansion and registrational path.

AKTX-101 demonstrated robust anti-tumor activity across multiple clinically relevant urothelial cancer preclinical models Data supports the potential of Akari’s novel PH1 RNA spliceosome-modulating...

Peer-reviewed research points to the extracellular matrix, the framework that holds tissue together, as central to that work. More than a decade of research has gone into Conexeu’s CXU™ Platform ...

PALM HARBOR, Fla., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Polomar Health Services, Inc. (OTCQB: PMHS) (“Polomar” or the “Company”), a healthcare services company operating a specialty compounding...

The world-first clinical study is a Phase 1b, open‑label, dose escalation and dose expansion study of PRP in patients with advanced solid tumors.

SOUTH SAN FRANCISCO, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the receipt of Fast Track designation from the U.S. Food and Drug...